Details

Titel

Biopolymers for Biomedical Applications

Auflage

1st ed

Ort / Verlag

Newark : John Wiley & Sons, Incorporated,

Erscheinungsjahr

2024

Link zum Volltext

• Wiley Online Library - AutoHoldings Books

Beschreibungen/Notizen

• Cover -- Title Page -- Copyright Page -- Dedication Page -- Contents -- Preface -- Chapter 1 Introduction to Biopolymers -- 1.1 Introduction -- 1.2 Classification of Biopolymers -- 1.3 Commonly Used Biopolymers -- 1.3.1 Chitosan -- 1.3.2 Alginate -- 1.3.3 Cellulose -- 1.3.4 Starch -- 1.3.5 Keratin -- 1.3.6 Carrageenan -- 1.3.7 Dextran -- 1.3.8 Curdlan -- 1.3.9 Collagen -- 1.3.10 Pectin -- 1.4 Preparation of Biopolymers -- 1.5 Commercially Available Biopolymers -- 1.6 Biomedical Applications of Biopolymers -- 1.6.1 Drug Delivery -- 1.6.2 Tissue Engineering -- 1.6.3 Wound Healing -- 1.6.4 Medical Implants -- 1.6.5 Gene Therapy -- 1.7 Conclusion -- References -- Chapter 2 Biomedical Applications of Chitosan and Its Derivatives -- 2.1 Introduction -- 2.2 Characteristics of Chitosan -- 2.2.1 Biodegradability -- 2.2.2 Toxicity of Chitosan -- 2.2.3 Biocompatibility of Chitosan -- 2.3 Application of Chitosan in Biomedicine -- 2.3.1 Antimicrobial Activity -- 2.3.2 Anticancer Agent -- 2.3.3 Tissue Engineering -- 2.3.3.1 Bone Tissue Engineering -- 2.3.3.2 Cartilage Tissue Engineering -- 2.3.3.3 Anti-Inflammatory Effects and Repair of Arthritic Tissue -- 2.3.4 Wound Healing -- 2.3.5 Hemostatic Activity -- 2.3.6 Fat Binder -- 2.3.7 Drug Delivery -- 2.3.8 Bioimaging and Gene Transfer -- 2.3.9 Enzyme Immobilizations for Biosensing -- 2.3.10 Green Chemistry -- 2.4 Conclusion -- References -- Chapter 3 Biomedical Applications of Alginates -- 3.1 Introduction -- 3.2 Structure and Characterization -- 3.3 General Properties of Alginates -- 3.3.1 Alginate Synthesis -- 3.3.2 Molecular Weight of Alginates -- 3.3.3 Solubility -- 3.3.4 Derivatives of Alginates -- 3.3.4.1 Amphiphilic Alginate -- 3.3.4.2 Cell-Interactive Alginate -- 3.4 Alginate and Alginate Composites as a Drug Delivery System -- 3.4.1 Fiber Form -- 3.4.2 Bead Form -- 3.4.3 Hydrogel Form.
• 3.5 Biomedical Application of Alginates -- 3.5.1 Wound Dressing -- 3.5.2 Heart and Cardiovascular Disease -- 3.5.3 Drug Delivery -- 3.5.4 Tissue Engineering -- 3.5.4.1 Bone Tissue Engineering -- 3.5.4.2 Cartilage -- 3.5.5 Liver Tissue Engineering -- 3.6 Conclusion and Future Prospective of Alginates -- References -- Chapter 4 Biomedical Applications of Cellulose -- 4.1 Introduction -- 4.2 Structure and Properties of Cellulose -- 4.3 Types of Cellulose -- 4.4 Applications of Cellulose -- 4.4.1 Drug Delivery -- 4.4.2 Antimicrobial Properties -- 4.4.3 Tissue Engineering -- 4.4.4 Biosensing and Diagnostic -- 4.4.5 Enzyme Immobilization -- 4.4.6 Wound Dressing/Healing -- 4.4.7 Applications in the Cardiovascular System -- 4.4.8 Cardiac Prosthetics -- 4.4.9 Replacement of Vascular Grafts -- 4.5 Applications in Ocular Systems -- 4.5.1 Artificial Cornea -- 4.5.2 Contact Lens -- 4.5.3 Retinal Pigments -- 4.6 Applications in Skeletal Systems -- 4.6.1 Bone Regeneration -- 4.6.2 Cartilage Invertebrate Disc -- 4.6.3 Meniscus Implants -- 4.6.4 Dental and Ligament Implants -- 4.7 Miscellaneous -- 4.8 Conclusion -- References -- Chapter 5 Biomedical Applications of Starch -- 5.1 Introduction -- 5.2 Structure and Properties of Starch -- 5.3 Modified Starches -- 5.3.1 Physical Modifications -- 5.3.2 Enzyme Modification -- 5.3.3 Chemical Modification -- 5.3.4 Cross-Linked Starch -- 5.3.5 Oxidized Starch -- 5.3.6 Converted Starches -- 5.4 Pharmaceutical and Biomedical Applications -- 5.5 Starch for Novel Drug Delivery -- 5.5.1 Drug Delivery Systems -- 5.6 Encapsulants -- 5.7 Micro/Nanoparticle Hydrogels -- 5.8 Scaffolds for Wound Healing -- 5.9 Conclusions -- References -- Chapter 6 Biomedical Applications of Carrageenan -- 6.1 Introduction -- 6.2 Structure of Carrageenan -- 6.3 Biomedical Applications -- 6.3.1 In Oral Drug Delivery -- 6.3.2 In Wound Healing.
• 6.3.3 Anticancer Activity -- 6.3.4 Anticoagulant Action -- 6.3.5 Anti-Mutagenic Activity -- 6.3.6 For Vaccines -- 6.4 Toxicity -- 6.5 Challenges, Conclusion, and Future Trends -- References -- Chapter 7 Biomedical Applications of Gums -- 7.1 Introduction -- 7.2 Physicochemical Properties of Gums -- 7.3 Biomedical Applications of Guar Gum -- 7.4 Biomedical Applications of Xanthan Gum -- 7.5 Biomedical Applications of Gum Arabic -- 7.6 Biomedical Applications of Gum Tragacanth -- 7.7 Conclusion and Future Perspective -- References -- Chapter 8 Biomedical Applications of Cyclodextrin -- Abbreviations -- 8.1 Introduction -- 8.2 Biomedical Applications of Cyclodextrin -- 8.2.1 CDs as a Scaffold in Tissue Engineering -- 8.2.2 CDs in Drug Delivery -- 8.2.3 CDs in Cancer Treatment -- 8.2.4 CDs in Gene Delivery -- 8.2.5 CDs in Biosensor and Biomarker -- 8.2.6 Cyclodextrin-Based Stimulus-Responsive Biomaterial Systems -- 8.3 Future Prospects -- 8.4 Conclusion -- References -- Chapter 9 Biomedical Applications of Dextran -- 9.1 Introduction -- 9.2 Biomedical Applications of Dextran -- 9.2.1 Bioanalysis and Imaging With Dextran -- 9.2.2 Drug Delivery Systems -- 9.2.3 Anticancer and Antimicrobial Conjugates -- 9.2.4 Dextran as a Local Anesthetic Adjuvant -- 9.2.5 Increased Retention Time at the Targeted Area -- 9.2.6 Treatment of Myocardial Infarction -- 9.2.7 Cell Delivery Efficiency -- 9.2.8 Post-Laminectomy Spinal Sheep Model -- 9.2.9 Wound Healing -- 9.2.10 Dextran With Nanoparticles -- 9.2.11 Dextran Hydrogels -- 9.2.12 Dextran Nanocomposite -- 9.3 Conclusion -- References -- Chapter 10 Biomedical Applications of Pullulan -- 10.1 Introduction -- 10.2 Sources of Pullulan -- 10.3 Properties of Pullulan -- 10.4 Biomedical Applications -- 10.4.1 Drug Delivery -- 10.4.2 Gene Delivery System -- 10.4.3 Tissue Engineering and Wound Healing -- 10.4.4 Medical Imaging.
• 10.4.5 Vaccination -- 10.4.6 Film-Forming Agent -- 10.4.7 Plasma Expander -- 10.4.8 Molecular Chaperones -- 10.4.9 Insulinotropic Activity -- 10.5 Conclusion -- References -- Chapter 11 Biomedical Applications of Collagen/Gelatin -- 11.1 Introduction -- 11.2 Structure of Collagen -- 11.2.1 Primary Structure -- 11.2.2 Secondary Structure -- 11.2.3 Tertiary Structure -- 11.2.4 Quaternary Structure -- 11.2.5 Super Molecular Aggregation Structure -- 11.3 Modification of Collagen -- 11.4 Biomedical Applications of Collagen/Gelatin -- 11.4.1 Collagen as Film or Membranes -- 11.4.2 Collagen as a Matrix -- 11.4.3 Collagen as Shields -- 11.4.4 Collagens as Sponges -- 11.4.5 Collagen as Hydrogels -- 11.4.6 Collagen as a Pellet -- 11.4.7 Nanoparticles/Microspheres/Nanospheres -- 11.4.7.1 Collagen Nanoparticle Fabrication Techniques -- 11.4.8 Collagen in Substitution of Skin -- 11.4.9 Collagen in Bone Tissue Engineering -- 11.4.10 Collagen in Tendon Repair -- 11.4.11 Collagen in Cartilage Repair -- 11.4.12 Collagen in Neural Repair -- 11.5 Conclusion -- References -- Chapter 12 Biomedical Applications of Pectin -- 12.1 Introduction -- 12.2 Biomedical Applications of Pectin -- 12.2.1 Pectin in Drug Administration -- 12.2.1.1 Pectin for Drug Delivery -- 12.2.1.2 Nasal Drug Delivery -- 12.2.1.3 Oral Drug Delivery -- 12.2.1.4 Ocular Drug Delivery -- 12.2.2 Cancer-Designated Drug Conveyance -- 12.2.3 Pectin Polyplexes for Gene Conveyance -- 12.2.4 Pectin Gels for Tissue Designing -- 12.2.5 Pectin in Wound-Mending Patches -- 12.2.6 Other Formulations -- 12.2.7 Conclusion -- References -- Chapter 13 Biomedical Applications of Lignin Derived from Bio-Waste Materials -- 13.1 Introduction -- 13.2 Structure of Lignin -- 13.3 Sources of Lignin -- 13.3.1 Lignin Derived from Natural Sources -- 13.3.2 Lignin Derived from Bio-Waste -- 13.3.2.1 Paper and Pulp Industry.
• 13.3.2.2 Forest Residue/Wood Waste -- 13.3.2.3 Agricultural Waste -- 13.3.2.4 Household and Food Industry Waste -- 13.4 Extraction of Lignin -- 13.4.1 Lignin Extraction from Biorefinery Biomass -- 13.4.1.1 Acid Hydrolysis of Biomass -- 13.4.1.2 Alkaline Hydrolysis -- 13.4.1.3 Enzymatic Hydrolysis of Biomass -- 13.4.1.4 Reductive Catalyst Fractionation of Biomass -- 13.4.2 Extraction of Lignin from Pulp and Paper Industry Biomass -- 13.4.2.1 Extraction of Sulphur-Bearing Lignin -- 13.4.2.2 Sulphur-Free Process -- 13.5 Properties of Lignin for Biomedical Applications -- 13.5.1 Molecular Weight -- 13.5.2 Thermal Characterization -- 13.5.3 Solubility -- 13.5.4 Relative Density and Color -- 13.5.5 Biocompatibility -- 13.5.6 Biodegradability -- 13.5.7 Antioxidant and Antimicrobial Properties -- 13.5.8 Anti-Ultraviolet Properties -- 13.6 Biomedical Applications of Lignin -- 13.6.1 Lignin in Hydrogel Development -- 13.6.2 Lignin in Wound Healing -- 13.6.3 Lignin in Drug Delivery -- 13.6.4 Lignin in Gene Delivery -- 13.6.5 Lignin in Tissue Engineering -- 13.7 Therapeutic Applications of Lignin -- 13.7.1 Treatment of Diabetes -- 13.7.2 Cancer Treatment -- 13.7.2.1 Antioxidant Properties -- 13.7.2.2 Cytotoxicity -- 13.7.3 Antimicrobial and Antiviral Activity -- 13.7.4 Anticoagulant Activity -- 13.7.5 Lignin in Cosmetics -- 13.8 Feasibilities, Challenges, and Prospects -- 13.9 Conclusion -- References -- Chapter 14 Biomedical Applications of Polycaprolactone -- 14.1 Introduction -- 14.2 Structure of PCL -- 14.3 Characteristic Properties of PCL -- 14.4 Synthesis -- 14.5 Modifications of PCL -- 14.6 Biomedical Applications of PCL -- 14.6.1 Drug Delivery -- 14.6.2 Suture -- 14.6.3 Tissue Engineering -- 14.6.4 Other Applications -- 14.7 Current Challenges -- 14.8 Conclusion -- References -- Chapter 15 Biopolymers for Wound Healing Applications -- 15.1 Introduction.
• 15.2 Wound Healing Stages.
• Description based on publisher supplied metadata and other sources.